« Previous
Next »
Leukemia Research
Volume 28, Issue 10
, Pages 1085-1088
, October 2004
Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates
References
- . Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J. Exp. Med. 1991;174:139–149
-
.
Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune response in vitro and in vivo.
Proc. Natl. Acad. Sci. U.S.A. 1998;95:9482–9487
- Establishment and characterization of mouse leukemia cell lines L615K and L7212K derived from transplantable murine leukemias maintained in China. Jpn. J. Cancer Res. 1989;80:444–451
- Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp. Hematol. 1993;21:1673–1679
- Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 1999;5:405–411
- Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J. Immunother. 2001;24:502–510
PII: S0145-2126(04)00054-2
doi: 10.1016/j.leukres.2004.01.014
© 2004 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 28, Issue 10
, Pages 1085-1088
, October 2004
